Antibodies to DNA.

Antibodies to DNA are of interest to a broad spectrum of physicians and other scientists. The presence of large amounts of serum antibodies to double-stranded DNA is specific for systemic lupus erythematosus, and some subgroups of these antibodies are pathogenic. It is likely that people are predisposed to have systemic lupus erythematosus if they can make pathogenic subgroups of antibodies to DNA and if they cannot down-regulate them appropriately. Studies of patients with systemic lupus erythematosus and of murine models of the disease have provided information regarding the different types of antibodies to DNA, their role in pathogenesis, and new . . .

[1]  F. Quismorio,et al.  CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. , 2010, Arthritis and rheumatism.

[2]  R. Kimberly,et al.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.

[3]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[4]  R M Smith,et al.  Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. , 1997, The Journal of clinical investigation.

[5]  Bernhard Hemmer,et al.  Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone , 1997, The Journal of experimental medicine.

[6]  R. Cantor,et al.  Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. , 1997, The Journal of clinical investigation.

[7]  A. Rosen,et al.  Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE , 1997, Lupus.

[8]  C. Burns,et al.  Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response. , 1996, Journal of immunology.

[9]  J. Lefkowith,et al.  Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. , 1996, The Journal of clinical investigation.

[10]  M. Hylkema,et al.  Significance of anti‐nuclear and anti‐extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice , 1996, Clinical and experimental immunology.

[11]  F. Dammacco,et al.  Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti‐DNA‐reactive IgG , 1996, Clinical and experimental immunology.

[12]  J. Thornton,et al.  Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. , 1996, Molecular immunology.

[13]  F. Arnett,et al.  Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. , 1996, The Journal of clinical investigation.

[14]  M. Abrahamowicz,et al.  Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. , 1996, Arthritis and rheumatism.

[15]  D. Isenberg,et al.  Human T cell responses to autoantibody variable region peptides , 1995, Lupus.

[16]  C. Kallenberg,et al.  Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. , 1995, Arthritis and rheumatism.

[17]  C. Mohan,et al.  Lupus: key pathogenic mechanisms and contributing factors. , 1995, Clinical immunology and immunopathology.

[18]  E. Sercarz,et al.  Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. , 1995, The Journal of clinical investigation.

[19]  A. Kumar,et al.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Isenberg,et al.  Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. , 1995, Kidney international.

[21]  T. Winkler,et al.  Preferential recognition of specific DNA motifs by anti‐double‐stranded DNA autoantibodies , 1995, European journal of immunology.

[22]  P. Limburg,et al.  Prevention of relapses in systemic lupus erythematosus , 1995, The Lancet.

[23]  B. Croker,et al.  Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system. , 1995, The Journal of rheumatology.

[24]  P. Yuan,et al.  Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy. , 1995, Artificial organs.

[25]  B. Tsao,et al.  Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. , 1995, Journal of immunology.

[26]  A. Theofilopoulos The basis of autoimmunity: Part II. Genetic predisposition. , 1995, Immunology today.

[27]  G. Denomme,et al.  The role of the immunoglobulin heavy chain in human anti-DNA antibody binding specificity. , 1995, Arthritis and rheumatism.

[28]  J. Harley,et al.  Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity , 1995, The Journal of experimental medicine.

[29]  Y. Shoenfeld Idiotypic induction of autoimmunity: a new aspect of the idiotypic network , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  P. Linsley,et al.  Treatment of murine lupus with CTLA4Ig. , 1994, Science.

[31]  R. Burlingame,et al.  The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. , 1994, The Journal of clinical investigation.

[32]  B. Tsao,et al.  Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. , 1994, International immunology.

[33]  W. Emlen,et al.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.

[34]  B. Stollar Molecular analysis of anti‐DNA antibodies , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  M. Satoh,et al.  Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. , 1994, Rheumatic diseases clinics of North America.

[36]  J. Swindle,et al.  Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. , 1993, Journal of immunology.

[37]  Y. Mizushima,et al.  Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. , 1993, Journal of immunology.

[38]  C. Mohan,et al.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus , 1993, The Journal of experimental medicine.

[39]  D. Pisetsky,et al.  The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. , 1993, Journal of autoimmunity.

[40]  B. Tsao,et al.  Ig-transgenic mice as models for studying the regulation and role of anti-DNA antibodies in murine lupus , 1992 .

[41]  U. Moens,et al.  Antibodies to Eukaryotic, including Autologous, Native DNA are Produced during BK Virus Infection, but not after Immunization with Non‐Infectious BK DNA , 1992, Scandinavian journal of immunology.

[42]  J. Kalden,et al.  Analysis of immunoglobulin variable region genes from human IgG anti‐DNA hybridomas , 1992, European journal of immunology.

[43]  H. Nishimura,et al.  Somatically mutated IgG anti‐DNA antibody clonally related to germ‐line encoded IgM anti‐DNA antibody , 1992, European journal of immunology.

[44]  M. Petri,et al.  Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. , 1991, Arthritis and rheumatism.

[45]  K. Yoshinaga,et al.  Anti-DNA idiotypes deposited in renal glomeruli of patients with lupus nephritis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  M. Petri,et al.  Comparison of different methods of classifying patients with systemic lupus erythematosus. , 1991, The Journal of rheumatology.

[47]  Willem,et al.  Somatic mutations in the variable regions of a human IgG anti-double- stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus , 1991, The Journal of experimental medicine.

[48]  M. Radic,et al.  Ig H and L chain contributions to autoimmune specificities. , 1991, Journal of immunology.

[49]  A. Todd-Pokropek,et al.  Comparison of DNA antibody idiotypes in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories. , 1990, Journal of autoimmunity.

[50]  P. Limburg,et al.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. , 1990, Arthritis and rheumatism.

[51]  P. Lipsky,et al.  In vitro autoantibody production by normal adult and cord blood B cells. , 1990, The Journal of clinical investigation.

[52]  K. Kalunian,et al.  Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humans. , 1989, Arthritis and rheumatism.

[53]  W. Seaman,et al.  Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.

[54]  R. Schwartz,et al.  Origins of anti-DNA autoantibodies. , 1985, The Journal of clinical investigation.

[55]  D. Alarcón-Segovia,et al.  Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells. , 1983, Clinical and experimental immunology.

[56]  A. Weinstein,et al.  Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus. , 1983, The American journal of medicine.

[57]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[58]  N. Abdou,et al.  Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. , 1981, The Journal of clinical investigation.

[59]  D. Gladman,et al.  Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. , 1979, The American journal of medicine.

[60]  G. Friou,et al.  Lupus Nephritis: Varying Complement-Fixing Properties of Immuvnoglobulin G Antibodies to Antigens of Cel Nuclei , 1968, Science.

[61]  P. Schur,et al.  Immunologic factors and clinical activity in systemic lupus erythematosus. , 1968, The New England journal of medicine.

[62]  B. Stollar,et al.  The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. , 1967, The Journal of clinical investigation.

[63]  H G KUNKEL,et al.  Complement Fixation with Cell Nuclei and DNA in Lupus Erythematosus , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[64]  F. Celada,et al.  A DNA-Reacting Factor in Serum of a Patient with Lupus Erythematosus Diffusus.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[65]  E. Holborow,et al.  A Serum Factor in Lupus Erythematosus with Affinity for Tissue Nuclei , 1957, British medical journal.

[66]  A. Komatsuda,et al.  IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. , 1997, Kidney international.

[67]  M. Zouali The structure of human lupus anti-DNA antibodies. , 1997, Methods.

[68]  M. Radic,et al.  Genetic and structural evidence for antigen selection of anti-DNA antibodies. , 1994, Annual review of immunology.

[69]  B. Diamond,et al.  The role of somatic mutation in the pathogenic anti-DNA response. , 1992, Annual review of immunology.

[70]  J. Berden,et al.  Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. , 1990, Immunology today.

[71]  J. Winfield,et al.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. , 1977, The Journal of clinical investigation.